DOI QR코드

DOI QR Code

Proportion of Ovarian Cancers in Overall Ovarian Masses in Thailand

  • Kunpalin, Yada (Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University) ;
  • Triratanachat, Surang (Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University) ;
  • Tantbirojn, Patou (Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University)
  • Published : 2014.10.11

Abstract

Background: The primary objective of this study was to assess the proportion of malignancies in ovarian masses during $1^{st}$ January 2002, to $31^{st}$ December 2011 at the Department of Obstetrics and Gynecology, King Chulalongkorn Memorial Hospital. A secondary objective was to evaluate associations with patients' clinical characteristics and ovarian malignancy proportion and subtypes. Materials and Methods: Retrospective descriptive study analyzed data of ovarian masses larger than 3 centimeters in maximal diameter, from the division of Gynecologic Cyto-Pathology at KCMH. SPSS software version 17 (SPSS, Inc, Chicago, IL, USA) was used. Results: A total number of 6,115 patients were included. Among the total ovarian masses studied, 13.7% were malignant. After the age of sixty, the proportion reached almost 40%. It was also above 20% in women younger than 20 years old. During premenarche period, proportion of ovarian malignancies was 50%. Only 1% of ovarian masses were found to be malignant during the pregnancy and post-partum periods. Parity decreased the probability of ovarian malignancy during postmenopausal years. Period of menopause did not have any impact on this probability. During the first two decades of life, germ cell malignancy dominated. As the age increased, the percentage of surface epithelial-stromal malignancy increased with a peak at the fifth decade. In contrast, malignant sex cord-stromal cell tumors occurred at a constant rate in each age group after the thirties. Conclusions: Proportion of ovarian cancers in each age group, menstrual and pregnancy status are similar. However there are differences in the distribution of ovarian subtypes especially for the surface epithelial-stromal category.

Keywords

References

  1. American Cancer Society (2014). Cancer facts and figures Atlanta, 17-8.
  2. Breen J, Denehy T (2008). Pediatric ovarian malignancies. Glob. libr. women's med, (ISSN: 1756-2228); DOI 10.3843/GLOWM.10251.
  3. Cicin I, Eralp Y, Saip P, et al (2009). Malignant ovarian germ cell tumors: a single-institution experience. Am J Clin Oncol, 32, 191-6. https://doi.org/10.1097/COC.0b013e3181841f2e
  4. Ferlay J, Soerjomataram I, Ervik M, et al (2013). Globocan 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase no. 11. Lyon, France: International agency for research on cancer, 2013
  5. Gao S, Liu N, Ma Y, et al (2012). Methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers in ovarian cancer risk. Asian Pac J Cancer Prev, 13, 569-73. https://doi.org/10.7314/APJCP.2012.13.2.569
  6. Gurung A, Hung T, Morin J, et al (2013). Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates. Histopathology, 62, 59-70. https://doi.org/10.1111/his.12033
  7. Haroon S, Idrees R, Zia A, et al (2014). Ovarian sex cord stromal tumours in children and young girls-a more than two decade clinicopathological experience in a developing country, Pakistan. Asian Pac J Cancer Prev, 15, 1351-5. https://doi.org/10.7314/APJCP.2014.15.3.1351
  8. Haroon S, Zia A, Idrees R, et al (2013). Clinicopathological spectrum of ovarian sex cord-stromal tumors; 20 years' retrospective study in a developing country. J Ovarian Res, 6, 87. https://doi.org/10.1186/1757-2215-6-87
  9. Khuhaprema T, Attasara P, Sriplung, H, et al (2013). Cancer in Thailand Vol. VII 2007-2009. ministry of public health, Bangkok, Thailand.
  10. Lee K H, Lee I H, Kim B G, et al (2009). Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean gynecologic oncology group study. Int J Gynecol Cancer, 19, 84-7. https://doi.org/10.1111/IGC.0b013e31819914c5
  11. Leiserowitz G S, Xing G, Cress R, et al (2006). Adnexal masses in pregnancy: how often are they malignant? Gynecol Oncol, 101, 315-21. https://doi.org/10.1016/j.ygyno.2005.10.022
  12. Lertkhachonsuk R, Termrungruanglert W, Vasuratna A, et al (2005). Malignant ovarian germ cell tumor in King Chulalongkorn memorial hospital. J Med Assoc Thai, 88, 124-8.
  13. Murthy N S, Shalini S, Suman G, et al (2009). Changing trends in incidence of ovarian cancer-the Indian scenario. Asian Pac J Cancer Prev, 10, 1025-30.
  14. Nakashima N, Nagasaka T, Fukata S, et al (1990). Study of ovarian tumors treated at Nagoya University Hospital 1965-1988. Gynecol Oncol, 37, 103-11. https://doi.org/10.1016/0090-8258(90)90317-E
  15. Oranratanaphan S, Khemapech N (2013). Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution. Asian Pac J Cancer Prev, 14, 4693-7. https://doi.org/10.7314/APJCP.2013.14.8.4693
  16. Sah S P, Uprety D, Rani S (2004). Germ cell tumors of the ovary: a clinicopathologic study of 121 cases from Nepal. J Obstet Gynaecol Res, 30, 303-8. https://doi.org/10.1111/j.1447-0756.2004.00198.x
  17. Sakuma M, Otsuki T, Yoshinaga K, et al (2010). Malignant transformation arising from mature cystic teratoma of the ovary: a retrospective study of 20 cases. Int J Gynecol Cancer, 20, 766-71. https://doi.org/10.1111/IGC.0b013e3181daaf1d
  18. Schumer S T, Cannistra S A (2003). Granulosa cell tumor of the ovary. J Clin Oncol, 21, 1180-9. https://doi.org/10.1200/JCO.2003.10.019
  19. Sung P L, Chang Y H, Chao K C,et al (2014). Global distribution pattern of histological subtypes of epithelial ovarian cancer: a database analysis and systematic review. Gynecol Oncol, 133, 147-54.
  20. Tangjitgamol S, Hanprasertpong J, Manusirivithaya S, et al (2010). Malignant ovarian germ cell tumors: clinicopathological presentation and survival outcomes. Acta Obstet Gynecol Scand, 89, 182-9. https://doi.org/10.3109/00016340903443684
  21. Tavassoli FA, Devilee P, et al (2003). Pathology and genetics of tumours of the breast and female genital organs. world health organization classification of tumours. IARC press: Lyon, 113-96.
  22. Trivijitsilp P, Trirattanachart S, Niruthisard S, et al (1999). The frequency of primary ovarian neoplasms at King Chulalongkorn Memorial Hospital during 1990-1997. Chula Med J, 43, 213-24.
  23. Tsilidis K K, Allen N E, Key T J, et al (2011). Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European prospective investigation into cancer and nutrition. Br J Cancer, 105, 1436-42. https://doi.org/10.1038/bjc.2011.371
  24. Wang B, Liu S Z, Zheng R S, et al (2014). Time trends of ovarian cancer incidence in China. Asian Pac J Cancer Prev, 15, 191-3. https://doi.org/10.7314/APJCP.2014.15.1.191
  25. Yoshikawa N, Kajiyama H, Kikkawa F, et al (2014). Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women. J Gynecol Oncol, 25, 118-23. https://doi.org/10.3802/jgo.2014.25.2.118

Cited by

  1. Improved Diagnostic Accuracy in Characterization of Adnexal Masses by Detection of Choline Peak Using 1H MR Spectroscopy in Comparison to Internal Reference at 3 Tesla vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.5085
  2. Incidence and Clinical Characteristic of Venous Thromboembolism in Gynecologic Oncology Patients attending King Chulalongkorn Memorial Hospital over a 10 Year Period vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6705
  3. Differentiation of Benign from Malignant Adnexal Masses by Functional 3 Tesla MRI Techniques: Diffusion-Weighted Imaging and Time-Intensity Curves of Dynamic Contrast-Enhanced MRI vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3407
  4. High-risk epithelial ovarian cancer patients for hereditary ovarian cancer vol.43, pp.5, 2017, https://doi.org/10.1111/jog.13287